Potential Promising Therapy for Alzheimer's disease

 

PeptiClere^™ is a small peptide compound that has been shown to prevent the formation and accumulation of the soluble and insoluble forms of beta-amyloid found in Alzheimer's victims. 

 

PeptiClere^™ is in the pre-clinical stage of development and we anticipate initiating our IND enabling studies within the next year.  This compound will be a treatment for mild to moderate stages of Alzheimer's disease.

 

ProteoTech's Peptide Therapeutics Program for Alzheimer’s disease